PTPN2 in the Immunity and Tumor Immunotherapy: A Concise Review

被引：17
|
作者：
Song, Jiachun [1 ]
Lan, Jinxin [1 ]
Tang, Jiaping [1 ]
Luo, Na [1 ]
机构：
[1] Nankai Univ, Sch Med, Dept Anat & Histol, Tianjin 300071, Peoples R China
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2022年 / 23卷 / 17期
基金：
中国国家自然科学基金;
关键词：
PTPN2; inflammation; tumor immunotherapy; PROTEIN-TYROSINE-PHOSPHATASE; BLOOD-BRAIN-BARRIER; NEGATIVE REGULATOR; ACTIVATION; IDENTIFICATION; TCPTP; PROLIFERATION; FAMILY; DIFFERENTIATION; LOCALIZATION;
D O I：
10.3390/ijms231710025
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
PTPN2 (protein tyrosine phosphatase non-receptor 2), also called TCPTP (T cell protein tyrosine phosphatase), is a member of the PTP family signaling proteins. Phosphotyrosine-based signaling of this non-transmembrane protein is essential for regulating cell growth, development, differentiation, survival, and migration. In particular, PTPN2 received researchers' attention when Manguso et al. identified PTPN2 as a cancer immunotherapy target using in vivo CRISPR library screening. In this review, we attempt to summarize the important functions of PTPN2 in terms of its structural and functional properties, inflammatory reactions, immunomodulatory properties, and tumor immunity. PTPN2 exerts synergistic anti-inflammatory effects in various inflammatory cells and regulates the developmental differentiation of immune cells. The diversity of PTPN2 effects in different types of tumors makes it a potential target for tumor immunotherapy.
引用
收藏
页数：14
相关论文
共 50 条
  • [1] Immune checkpoint PTPN2 predicts prognosis and immunotherapy response in human cancers
    Tang, Xiaolong
    Sui, Xue
    Liu, Yongshuo
    HELIYON, 2023, 9 (01)
  • [2] The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity
    Baumgartner, Christina K.
    Ebrahimi-Nik, Hakimeh
    Iracheta-Vellve, Arvin
    Hamel, Keith M.
    Olander, Kira E.
    Davis, Thomas G. R.
    McGuire, Kathleen A.
    Halvorsen, Geoff T.
    Avila, Omar I.
    Patel, Chirag H.
    Kim, Sarah Y.
    Kammula, Ashwin V.
    Muscato, Audrey J.
    Halliwill, Kyle
    Geda, Prasanthi
    Klinge, Kelly L.
    Xiong, Zhaoming
    Duggan, Ryan
    Mu, Liang
    Yeary, Mitchell D.
    Patti, James C.
    Balon, Tyler M.
    Mathew, Rebecca
    Backus, Carey
    Kennedy, Domenick E.
    Chen, Angeline
    Longenecker, Kenton
    Klahn, Joseph T.
    Hrusch, Cara L.
    Krishnan, Navasona
    Hutchins, Charles W.
    Dunning, Jax P.
    Bulic, Marinka
    Tiwari, Payal
    Colvin, Kayla J.
    Chuong, Cun Lan
    Kohnle, Ian C.
    Rees, Matthew G.
    Boghossian, Andrew
    Ronan, Melissa
    Roth, Jennifer A.
    Wu, Meng-Ju
    Suermondt, Juliette S. M. T.
    Knudsen, Nelson H.
    Cheruiyot, Collins K.
    Sen, Debattama R.
    Griffin, Gabriel K.
    Golub, Todd R.
    El-Bardeesy, Nabeel
    Decker, Joshua H.
    NATURE, 2023, 622 (7984) : 850 - +
  • [3] Characterization of PTPN2 and its use as a biomarker
    Bussieres-Marmen, Stephanie
    Hutchins, Andrew P.
    Schirbel, Anja
    Rebert, Nancy
    Tiganis, Tony
    Fiocchi, Claudio
    Miranda-Saavedra, Diego
    Tremblay, Michel L.
    METHODS, 2014, 65 (02) : 239 - 246
  • [4] Inhibition of PTPN2 by PTP inhibitor V
    Kim, Younghyun
    Cho, Sayeon
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2013, 34 (12): : 3874 - 3876
  • [5] PTPN2 regulates the generation of exhausted CD8+ T cell subpopulations and restrains tumor immunity
    LaFleur, Martin W.
    Nguyen, Thao H.
    Coxe, Matthew A.
    Miller, Brian C.
    Yates, Kathleen B.
    Gillis, Jacob E.
    Sen, Debattama R.
    Gaudiano, Emily F.
    Al Abosy, Rose
    Freeman, Gordon J.
    Haining, W. Nicholas
    Sharpe, Arlene H.
    NATURE IMMUNOLOGY, 2019, 20 (10) : 1335 - +
  • [6] PTPN2 negatively regulates macrophage inflammation in atherosclerosis
    Hu, Xiaorong
    Ma, Ruisong
    Cao, Jianlei
    Du, Xianjin
    Cai, Xinyong
    Fan, Yongzhen
    AGING-US, 2021, 13 (02): : 2768 - 2779
  • [7] PTPN2 Regulates Interactions Between Macrophages and Intestinal Epithelial Cells to Promote Intestinal Barrier Function
    Spalinger, Marianne R.
    Sayoc-Becerra, Anica
    Santos, Alina N.
    Shawki, Ali
    Canale, Vinicius
    Krishnan, Moorthy
    Niechcial, Anna
    Obialo, Nicole
    Scharl, Michael
    Li, Jiang
    Nair, Meera G.
    McCole, Declan F.
    GASTROENTEROLOGY, 2020, 159 (05) : 1763 - +
  • [8] Small-molecule PTPN2 Inhibitors Sensitize Resistant Melanoma to Anti-PD-1 Immunotherapy
    Zhu, Zhouting
    Tang, Rachel
    Huff, Sarah
    Kummetha, Indrasena Reddy
    Wang, Lingling
    Li, Na
    Rana, Tariq M.
    CANCER RESEARCH COMMUNICATIONS, 2023, 3 (01): : 119 - 129
  • [9] A small molecule inhibitor of PTP1B and PTPN2 enhances T cell anti-tumor immunity
    Liang, Shuwei
    Tran, Eric
    Du, Xin
    Dong, Jiajun
    Sudholz, Harrison
    Chen, Hao
    Qu, Zihan
    Huntington, Nicholas D.
    Babon, Jeffrey J.
    Kershaw, Nadia J.
    Zhang, Zhong-Yin
    Baell, Jonathan B.
    Wiede, Florian
    Tiganis, Tony
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [10] Reduced expression of phosphatase PTPN2 promotes pathogenic conversion of Tregs in autoimmunity
    Svensson, Mattias N. D.
    Doody, Karen M.
    Schmiedel, Benjamin J.
    Bhattacharyya, Sourya
    Panwar, Bharat
    Wiede, Florian
    Yang, Shen
    Santelli, Eugenio
    Wu, Dennis J.
    Sacchetti, Cristiano
    Gujar, Ravindra
    Seumois, Gregory
    Kiosses, William B.
    Aubry, Isabelle
    Kim, Gisen
    Mydel, Piotr
    Sakaguchi, Shimon
    Kronenberg, Mitchell
    Tiganis, Tony
    Tremblay, Michel L.
    Ay, Ferhat
    Vijayanand, Pandurangan
    Bottini, Nunzio
    JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (03) : 1193 - 1210
12345